CRISPR Therapeutics AG (CRSP) News
Track canonical SquawkNews coverage tagged to CRSP, CRISPR Therapeutics AG. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 9 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Anthropic AI Discovery Gene-Editing Stocks Falling
Gene-editing stocks fell Wednesday after Anthropic's Claude AI model identified an enzyme system with characteristics similar to technology used to alter DNA.Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Intellia
NEWS | Sep 24, 2026, 12:51 PM UTC
L
CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks?
Gene-editing stocks sold off on Wednesday after Anthropic said its Claude model had flagged a phage enzyme system that shares a few design traits with CRISPR — the platform behind approved and experimental DNA-editing me
EQUITY | Sep 23, 2026, 09:49 PM UTC
L
Cathie Wood Makes Striking Switch Between AI Stock Giants
Cathie Wood's Ark Invest made a sharp rotation across technology and biotechnology stocks last week, buying roughly $28 million of Meta Platforms NASDAQ:META while selling a nearly identical dollar amount of Alphabet NAS
EQUITY | Sep 15, 2026, 12:21 PM UTC
L
CRSP: CASGEVY and three late-stage assets drive growth, with pivotal data and global expansion ahead
CASGEVY’s pediatric label expansion and strong payer coverage are driving rapid revenue growth, while three key assets—CTX310, zugo-cel, and CTX611—are advancing toward pivotal trials. The pipeline is supported by robust
NEWS | Sep 14, 2026, 06:42 PM UTC
L
CRSP to Present at Morgan Stanley 24th Annual Global Healthcare Conference
CRISPR Therapeutics (CRSP) plans a conference presentation at the Morgan Stanley 24th Annual Global Healthcare Conference.
EQUITY | Sep 08, 2026, 12:32 PM UTC
H
Investors Shrug Off Good News for Heart Patients From New Meds — Barrons.com
By Bill AlpertThis year's run in drug stocks gained vigor from new treatments for heart attacks and strokes. Maybe some of those stocks are losing wind.At this past weekend's congress of the European Society of Cardiolog
GEOPOLITICS | Sep 01, 2026, 07:27 PM UTC
L
CRSP shares slip 3% despite ‘encouraging’ CTX310 data
CRSP shares fell 3% after ‘encouraging’ CTX310 data, with Morgan Stanley saying investor focus is further ahead.
EQUITY | Aug 28, 2026, 07:20 PM UTC
L
CRSP presents Phase 1a CTX310 data at ESC Congress 2026
CRISPR Therapeutics presented Phase 1a data for CTX310 at ESC Congress 2026, including ANGPTL3 editing and triglyceride and LDL lowering.
GEOPOLITICS | Aug 28, 2026, 02:37 PM UTC
H
CRISPR Therapeutics Q2 Revenue Jumps 151%
CRISPR Therapeutics Q2 revenue rises to $76M
EQUITY | Aug 03, 2026, 08:19 PM UTC
L
CRSP Reports Q2 Loss of $0.94 Per Share
CRSP posts Q2 loss of $0.94 per share
EARNINGS | Aug 03, 2026, 08:18 PM UTC
L
CRSP - CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
CRSP - CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
EARNINGS | Aug 03, 2026, 08:15 PM UTC
L
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at on our options activity scanner. Traders often look for
EQUITY | Jul 01, 2026, 05:35 PM UTC